DocuSign (DOCU) Expected to Announce Quarterly Earnings on Thursday

DocuSign (NASDAQ:DOCU) is projected to post its quarterly earnings results after the market closes on Thursday, March 13th. Analysts expect DocuSign to post earnings of $0.84 per share and revenue of $760.94 million for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

DocuSign Stock Performance

Shares of NASDAQ DOCU opened at $79.50 on Wednesday. DocuSign has a 52 week low of $48.70 and a 52 week high of $107.86. The stock has a market capitalization of $16.06 billion, a P/E ratio of 16.39, a PEG ratio of 6.94 and a beta of 1.02. The stock’s fifty day moving average is $88.57 and its 200 day moving average is $79.06.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on DOCU. Morgan Stanley lifted their price target on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research note on Friday, December 6th. JMP Securities reissued a “market outperform” rating and issued a $124.00 price target on shares of DocuSign in a research note on Tuesday, January 7th. UBS Group boosted their price target on DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. Hsbc Global Res raised DocuSign to a “moderate sell” rating in a research note on Friday, December 6th. Finally, JPMorgan Chase & Co. raised DocuSign from an “underweight” rating to a “neutral” rating and boosted their price target for the company from $70.00 to $75.00 in a research note on Monday. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $92.91.

Insider Buying and Selling

In other DocuSign news, Director Teresa Briggs sold 534 shares of the business’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $94.60, for a total value of $50,516.40. Following the transaction, the director now owns 7,736 shares of the company’s stock, valued at approximately $731,825.60. The trade was a 6.46 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Allan C. Thygesen sold 40,000 shares of the business’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $90.04, for a total value of $3,601,600.00. Following the completion of the transaction, the chief executive officer now directly owns 156,050 shares in the company, valued at approximately $14,050,742. This represents a 20.40 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 104,422 shares of company stock worth $9,665,394. 1.66% of the stock is owned by corporate insiders.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.